Markets:

Overview

News

Currencies

International

Treasuries

ACELYRIN, INC. - Common Stock (NQ:SLRN)

2.270 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ACELYRIN, INC. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors

October 13, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors

October 12, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors

October 12, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

NASDAQ:SLRN Shareholder Notice: Investigation over Possible Securities Laws Violations by Acelyrin, Inc. ↗

October 06, 2023

San Diego, CA -- (SBWIRE) -- 10/06/2023 -- An investigation was announced over potential securities laws violations by Acelyrin, Inc in connection with certain financial statements.

Via SBWire

ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development

October 03, 2023

From Acelyrin, Inc.

Via GlobeNewswire

Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs ↗

September 30, 2023

The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.

Via InvestorPlace

ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Acelyrin Stockholders and Encourages Investors to Contact the Firm

September 28, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Why Acelyrin Stock Plummeted 59% This Week ↗

September 15, 2023

The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.

Via The Motley Fool

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 13, 2023

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...

Via Benzinga

Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism ↗

September 12, 2023

Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe Hidradenitis Suppurativa (HS).

Via Benzinga

Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher ↗

September 12, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded up 0.11% to 34,702.55 while the NASDAQ fell 0.86% to 13,797.73....

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023 ↗

September 13, 2023

Via Benzinga

Dow Turns Higher; Oracle Shares Tumble After Q1 Results ↗

September 12, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Tuesday. The Dow traded up 0.22% to 34,740.15 while the NASDAQ fell 0.55% to 13,841.02. The S&P 500, also fell,...

Via Benzinga

Topics Stocks

Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday ↗

September 12, 2023

A competitor's clinical trial stumble may be benefiting MoonLake.

Via The Motley Fool

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 12, 2023

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

Via Benzinga

DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories ↗

September 12, 2023

Benzinga

Via Benzinga

Is American Battery Technology Company (ABML) Stock Really Up 1,300%? ↗

September 12, 2023

American Battery Technology Company (ABML) stock surprised investors Tuesday morning when it appeared to rocketing more than 1,300% higher.

Via InvestorPlace

Dow Falls 75 Points; US Small Business Optimism Drops In August ↗

September 12, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.22% to 34,587.58 while the NASDAQ fell 0.21%...

Via Benzinga

Topics Stocks

Why Is Datasea (DTSS) Stock Down 39% Today? ↗

September 12, 2023

Datasea (DTSS) stock is falling on Tuesday after the company announced a proposed public stock offering priced at 40 cents per share.

Via InvestorPlace

The Surprising Acelyrin News That Sent Rival MoonLake, A Top 1% Stock, Soaring 19% ↗

September 12, 2023

The companies are both working on treatments for a rare skin disease.

Via Investor's Business Daily

Why Is Acelyrin (SLRN) Stock Down 58% Today? ↗

September 12, 2023

Acelyrin (SLRN) stock is falling hard on Tuesday after the biopharma company announced lackluster clinical trial results.

Via InvestorPlace

Why Is Skin Disorders Focused Acelyrin Stock Trading Lower Today? ↗

September 12, 2023

Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe

Via Benzinga

Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗

September 12, 2023

Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 12, 2023

It's time to start the day off with a breakdown of the biggest pre-market stock movers worth watching on Tuesday morning!

Via InvestorPlace

Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

September 12, 2023

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa

September 11, 2023

From Acelyrin, Inc.

Via GlobeNewswire

ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

September 06, 2023

From Acelyrin, Inc.

Via GlobeNewswire

The Truth About IPO Investing ↗

September 02, 2023

When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are...

Via Talk Markets

Topics Initial Public Offering

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.